GSK

1,858.5

-0.83%↓

GSK

1,858.5

-0.83%↓

GSK

1,858.5

-0.83%↓

GSK

1,858.5

-0.83%↓

GSK

1,858.5

-0.83%↓

Search

Haleon PLC

Fechado

SetorSaúde

343.7 1.06

Visão Geral

Variação de preço das ações

24h

Atual

Mín

341.1

Máximo

343.8

Indicadores-chave

By Trading Economics

Rendimento

403M

Vendas

2.7B

P/E

Médio do Setor

17.216

51.415

EPS

0.044

Rendimento de Dividendos

2.14

Margem de lucro

14.708

Funcionários

24,535

EBITDA

697M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+29.65% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

2.14%

2.34%

Próximos Ganhos

30 de jul. de 2026

Próxima data de ex-dividendo

13 de ago. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

29B

Abertura anterior

342.64

Fecho anterior

343.7

Sentimento de Notícias

By Acuity

46%

54%

144 / 345 Ranking em Healthcare

Haleon PLC Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

29 de abr. de 2026, 07:48 UTC

Ganhos

Sensodyne-Maker Haleon Revenue Rises on Oral Health Growth -- Update

29 de abr. de 2026, 06:39 UTC

Ganhos

Sensodyne-maker Haleon Revenue Rises on Oral Health Growth

25 de fev. de 2026, 07:55 UTC

Ganhos

Panadol Maker Haleon Reports Revenue Slowdown Amid Weak Cold-And-Flu Season

29 de abr. de 2026, 08:05 UTC

Conversa de Mercado
Ganhos

Haleon's North America Results Were Encouraging -- Market Talk

29 de abr. de 2026, 07:46 UTC

Conversa de Mercado
Ganhos

Haleon's First-Quarter Results Align With Peers -- Market Talk

29 de abr. de 2026, 06:07 UTC

Ganhos

Haleon: 1Q Emerging Markets Revenue Growth 4.3%

29 de abr. de 2026, 06:06 UTC

Ganhos

Haleon: Q1 North America Organic Revenue Growth 1.0%

29 de abr. de 2026, 06:05 UTC

Ganhos

Haleon 1Q Reported Revenue Growth 0.1%

29 de abr. de 2026, 06:04 UTC

Ganhos

Analysts Saw Haleon 1Q Organic Revenue Growth 2.3%

29 de abr. de 2026, 06:04 UTC

Ganhos

Haleon 1Q Organic Revenue Growth 2.2%

29 de abr. de 2026, 06:04 UTC

Ganhos

Haleon 1Q Rev GBP2.86B

29 de abr. de 2026, 06:04 UTC

Ganhos

Haleon Sees High-single Digit Adjusted Operating Profit Growth at Constant Currency in Medium Term

29 de abr. de 2026, 06:03 UTC

Ganhos

Haleon Sees 4% to 6% Organic Rev Growth in Medium Term

29 de abr. de 2026, 06:03 UTC

Ganhos

Haleon Expects a Broadly Neutral Foreign Exchange Translation Impact on Net Rev, Adj Oper Pft

29 de abr. de 2026, 06:02 UTC

Ganhos

Haleon Sees 2026 Adjusted Effective Tax Rate c.24.5%

29 de abr. de 2026, 06:02 UTC

Ganhos

Haleon: Sees 2026 Net Interest GBP255 Million

29 de abr. de 2026, 06:02 UTC

Ganhos

Haleon Sees 2026 High-single Digit Adj Oper Pft Growth at Constant Currency

29 de abr. de 2026, 06:01 UTC

Ganhos

Haleon Sees 2026 Organic Revenue Growth 3% to 5%

25 de fev. de 2026, 07:18 UTC

Ganhos

Haleon 4Q Organic Revenue Growth 2.1%

25 de fev. de 2026, 07:17 UTC

Ganhos

Haleon: GBP500M Allocated to Share Buybacks in 2026

25 de fev. de 2026, 07:16 UTC

Ganhos

Haleon Sees 2026 High Single Digit Adj. Operating Profit Growth at Constant Currency

25 de fev. de 2026, 07:15 UTC

Ganhos

Haleon Sees 2026 Organic Revenue Growth of 3% to 5%

25 de fev. de 2026, 07:06 UTC

Ganhos

Haleon Declares Final Dividend of 4.9p

25 de fev. de 2026, 07:05 UTC

Ganhos

Haleon 2025 Net Pft GBP1.67B

25 de fev. de 2026, 07:05 UTC

Ganhos

Haleon 2025 Pretax Pft GBP2.15B

25 de fev. de 2026, 07:04 UTC

Ganhos

Analysts Saw Haleon 2025 Adj Oper Pft at GBP2.46B

25 de fev. de 2026, 07:04 UTC

Ganhos

Analysts Saw Haleon 2025 Adj Oper Pft Margin at 22.3%

25 de fev. de 2026, 07:04 UTC

Ganhos

Analysts Saw Haleon 2025 Organic Revenue Growth at 3.4%

25 de fev. de 2026, 07:04 UTC

Ganhos

Analysts Saw Haleon 2025 Rev at GBP11.03B

25 de fev. de 2026, 07:04 UTC

Ganhos

Haleon 2025 Adj. Operating Pft Margin 22.9%

Comparação entre Pares

Variação de preço

Haleon PLC Previsão

Preço-alvo

By TipRanks

29.65% parte superior

Previsão para 12 meses

Média 426.67 GBX  29.65%

Máximo 512 GBX

Mínimo 325 GBX

Com base em 10 analistas de Wall Street que oferecem metas de preço de 12 meses para Haleon PLC - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

10 ratings

7

Comprar

2

Manter

1

Vender

Sentimento

By Acuity

144 / 345 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Haleon PLC

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
help-icon Live chat